Product Description
Ovireg-21 Days Tablets contain Desogestrel BP 0.15 mg & Ethinylestradiol IP 0.03 mg, a combined oral contraceptive pill. Available from Pharmakon Lifesciences, Karnal, for PCD franchise and third-party manufacturing.
Indications
Contraception
Cycle regulation (as prescribed)
Dosage
As directed by the physician.
Side Effects
Nausea, breast tenderness, headache, spotting or mood changes may occur. Use only under the supervision of a gynaecologist.
Storage Instructions
Store in a cool, dry place below 30°C, protected from light and moisture.
Keep out of the reach of children.
Availability
Ovireg-21 Days Tablets is available for PCD Pharma Franchise distribution and Third-Party Contract Manufacturing across India. Reach out to the manufacturer for pricing, MOQ and territory details.
Pharmaceutical Specifications
| Product Name | Ovireg-21 Days Tablets |
| Dosage Form | Tablet |
| Composition | Desogestrel BP 0.15 mg & Ethinylestradiol IP 0.03 mg |
| Strength | N/A |
| Packing | 10x1x21 Blister (Mono Carton) |
| MRP | On Request |
| Prescription | Rx Required |
| Manufactured by | Pharmakon Lifesciences, Karnal |
| Delivery Time | 15–25 working days |
| Certifications | ISO 9001:2015 · WHO-GMP · Verified Company |
Company Information
Pharmakon Lifesciences
Karnal-based pharma company offering PCD franchise and third-party manufacturing in neuro, derma, gynae, ortho, dental and paediatric ranges. Operating since 2018.